Astrazeneca PLC (AZN)

Why Astrazeneca (AZN) is a Top Dividend Stock for Your Portfolio

Zacks Investment Research

The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes

Zacks Investment Research

Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx

Zacks Investment Research

Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update

Zacks Investment Research

Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates

Zacks Investment Research

Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect

Zacks Investment Research

AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up

Zacks Investment Research

Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?

Benzinga

AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript

The Motley Fool

Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales

Zacks Investment Research

Sanofi (SNY) Q1 Earnings In Line, Sales Miss Estimates, Stock Up

Zacks Investment Research

Q1 GDP Increased Lower Than Expectations

Zacks Investment Research

Is "Bad News" Still "Good News" for the Market?

Zacks Investment Research

Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks Investment Research

US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst

Benzinga

AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect

Zacks Investment Research

Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics

Zacks Investment Research

Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week

Benzinga

Astrazeneca (AZN) Could Be a Great Choice

Zacks Investment Research

Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick

Benzinga

International Wide-Moat Stocks On Sale - The April 2024 Heat Map

Seeking Alpha

4 Exceptional Growth Stocks You'll Regret Not Buying in the New Nasdaq Bull Market

The Motley Fool

AstraZeneca's (AZN) Fasenra Gets FDA Nod for Asthma in Kids

Zacks Investment Research

Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News

Zacks Investment Research

Astrazeneca (AZN) Outperforms Broader Market: What You Need to Know

Zacks Investment Research

Atossa (ATOS) Reports Positive Results From EVANGELINE Study

Zacks Investment Research

Nurix (NRIX) Up on Upbeat Initial Data From Phase I Cancer Study

Zacks Investment Research

Pfizer's (PFE) RSV Vaccine Study in Adults Under 60 Meets Goal

Zacks Investment Research

Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)

Zacks Investment Research

AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors

Zacks Investment Research

US Manufacturing Hits 18-Month High, China's Growth Could Trigger Deflation And More: Economics Weekly Roundup

Benzinga

Astrazeneca (AZN) Advances But Underperforms Market: Key Facts

Zacks Investment Research

AstraZeneca's (AZN) Imfinzi Improves Survival in SCLC Study

Zacks Investment Research

US Labor Market Heats Up In March: Payrolls Grow By 303,000, Highest In 10 Months, Dampen June Rate Cut Hopes (UPDATED)

Benzinga

US Labor Market Heats Up In March: Payrolls Grow By 303,000, Highest In 10 Months, Dampen Rate Cut Hopes

Benzinga

Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III

Zacks Investment Research

Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up

Zacks Investment Research

The Zacks Analyst Blog Highlights Berkshire Hathaway, Procter & Gamble, Adobe, Advanced Micro Devices and AstraZeneca

Zacks Investment Research

Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug

Zacks Investment Research

Top Research Reports for Berkshire Hathaway, Procter & Gamble & Adobe

Zacks Investment Research

Are You Looking for a High-Growth Dividend Stock?

Zacks Investment Research

AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance

Zacks Investment Research

AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod

Zacks Investment Research

Astrazeneca (AZN) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks Investment Research

AstraZeneca PLC (AZN) is Attracting Investor Attention: Here is What You Should Know

Zacks Investment Research

Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs

Zacks Investment Research

Bull Market Buys: 3 Dividend Stocks to Own for the Long Run

The Motley Fool

Astrazeneca (AZN) Rises As Market Takes a Dip: Key Facts

Zacks Investment Research

Novo Nordisk (NVO) to Buy Cardior to Boost Heart Disease Pipeline

Zacks Investment Research

AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication

Zacks Investment Research